The invasive ability of cancer cells is acquired via transformation to a mesenchymal phenotype, during which the expression of the EMT markers N‐cadherin, E‐cadherin and vimentin changes.15 Although ATF3 promotes EMT in breast cancer, the mechanism of ATF3 in EMT depends on the tumour type. This evidence concerns the gene VIM and cancer.